Podcasts about Kindler

Tue, 25 Mar 2025 15:38:14 +0000 https://sozial.podigee.io/21-new-episode 8fec0e2b6ff88c87c1faab6ab89b86ab Ein Nazi in der Sozialen Arbeit: Das kann sich kaum jemand vorstellen. Denn eine rechtsextreme Gesinnung geht von einer naturgegebenen Ungleichheit der Menschen aus. Aber müssen Sozialarbeitende zwingend politisch links sein? Diese Frage beschäftigt ZHAW-Dozent Konstantin Kehl, seit ein Student ihm mitteilte, dass er einige konservative Positionen vertrete, die nicht mit der Mehrheit seiner Kommiliton:innen übereinstimme. In der neusten Episode des Podcasts «sozial» diskutiert Kehl darüber mit Tobias Kindler von der Fachhochschule OST, der seine Doktorarbeit zum Thema Politische Soziale Arbeit («Social workers in the policy process») schreibt. Kindler verweist auf den Berufskodex, nach dem Soziale Arbeit eine normative Profession ist. Doch was bedeutet es für eine Gesellschaft, wenn es einen politischen Rechtsruck gibt? Wie viel «Rechts» müssen Sozialarbeitende tolerieren? Und inwiefern könnten sie sich an Rosmarie Dormann, die von 1987 bis 2003 für die CVP (heute Die Mitte) im Nationalrat sass, ein Beispiel nehmen? Literatur: Der Berufskodex Soziale Arbeit kann auf der Website des Berufsverbandes AvenirSocial kostenlos heruntergeladen werden. Kindler, Tobias & Kehl, Konstantin (2024): Policy Entrepreneurship in der Sozialen Arbeit: Drei Fallbeispiele aus der Schweiz. In: Schmidtke, Birgit; Kolbinger, Martin Lu & Molzbichler, Daniela (Hrsg.): Sozial - Innovativ - Nachhaltig: Herausforderungen und Perspektiven für die Sozialwirtschaft. Wiesbaden: Springer. S. 341-357. Verfügbar unter: https://doi.org/10.1007/978-3-658-42847-1_17 (kostenlos mit ZHAW-Bibliotheksaccount). Wollt ihr mehr über Soziale Arbeit hören und lesen? Wir informieren euch über News aus Forschung, Studium und Weiterbildung in unserem Newsletter – jetzt abonnieren. 21 full no politik,soziale arbeit,gesinnung,rechtsextrem,positionen ZHAW Soziale Arbeit

Vor der entscheidenden Sitzung des Bundestags zur Lockerung der Schuldenbremse sprechen wir mit dem haushaltspolitischen Sprecher der Grünen, Sven-Christian Kindler, über die harten Verhandlungen mit der CDU und seine kurzfristige Rückkehr in den Bundestag. Eine entscheidende Rolle kommt auch den Bundesländern zu. Unser Korrespondent für Rheinland-Pfalz, Timo Steppat, erläutert, warum ausgerechnet die FDP das Zünglein an der Waage sein könnte.

Plank has fun on the social medias. KJ Kindler joins the show.

.

Oklahoma Softball gets a scare. KJ Kindler joins the show.

.

.

Icy roadways. KJ Kindler joins the show.

Opening Day for OU Baseball arrives. KJ Kindler joins.

Mark Williams, KJ Kindler join.

Simsalabim Sabrina und Jean J.P.K. Kindler kommen in der Außenstelle Studio Rot Bonn-Beuel zusammen und melden sich zwischen den Shows in Bonn, Düsseldorf, Mainz und Trier bei Euch. Wie schön es immer ist, wenn man von Angesicht zu Angesicht konversieren kann! Merkt man auch direkt, das schiebt!

.

What's next in the OU DC search? Corey Wilson, KJ Kindler joins.

.

Ohio State captures the national championship. Dusty Dvoracek, KJ Kindler join.

.

KJ Kindler joins the show.

Dr. Hedy Kindler joins us on the podcast to discuss the latest update to the treatment of pleural mesothelioma guideline. She discusses the latest changes to the updated recommendations across topics including surgery, immunotherapy, chemotherapy, pathology, and germline testing. Dr. Kindler describes the impact of this guideline and the need for ongoing research in the field. Read the full guideline update, “Treatment of Pleural Mesothelioma: ASCO Guideline Update” at www.asco.org/thoracic-cancer-guidelines.   TRANSCRIPT This guideline, clinical tools, and resources are available at http://www.asco.org/thoracic-cancer-guidelines. Read the full text of the guideline and review authors' disclosures of potential conflicts of interest in the Journal of Clinical Oncology, https://ascopubs.org/doi/10.1200/JCO-24-02425 Brittany Harvey: Hello and welcome to the ASCO Guidelines podcast, one of ASCO's podcasts delivering timely information to keep you up to date on the latest changes, challenges, and advances in oncology. You can find all the shows, including this one at asco.org/podcasts. My name is Brittany Harvey and today I'm interviewing Dr. Hedy Kindler from the University of Chicago, lead author on “Treatment of Pleural Mesothelioma: ASCO Guideline Update.” Thank you for being here today, Dr. Kindler. Dr. Hedy Kindler: Thank you so much. Brittany Harvey: Then, before we discuss this guideline, I'd like to note that ASCO takes great care in the development of its guidelines in ensuring that the ASCO Conflict of Interest Policy is followed for each guideline. The disclosures of potential conflicts of interest for the guideline panel, including Dr. Kindler, who has joined us here today, are available online with the publication of the guideline in the Journal of Clinical Oncology, which is linked in the show notes. So then, to jump into the content of this podcast episode, first, Dr. Kindler, can you provide an overview of the purpose and scope of this guideline update on pleural mesothelioma? Dr. Hedy Kindler: The initial ASCO practice guideline on mesothelioma, which we published in 2018, was quite comprehensive, but since that time incredible progress has been made which has truly transformed the management of this disease. So we felt it was really important to update the guideline now, focusing on four key areas: the role of surgery, new systemic treatments, pathologic insights, and germline testing. Brittany Harvey: Great. Thank you for highlighting those key areas of the guideline. And so I'd like to next review the key updated recommendations for our listeners. So starting with what are the new updates for surgery? Dr. Hedy Kindler: So surgery has always been controversial in meso, with significant geographic variation in its use. Now, it's even more controversial. Recent randomized data from the MARS 2 trial, placed in the context of other data we also reviewed in this update, suggest that surgical cytoreduction should not be routinely offered to all patients based solely on anatomic resectability. Surgery should only be offered to highly selected patients with favorable prognostic characteristics. This includes comprehensively staged patients with early-stage epithelioid tumors. Patients should preferably be treated at centers of excellence which have documented low morbidity and mortality, and this should also be done in the context of multimodality therapy and preferably within clinical trials. Brittany Harvey: Understood. I appreciate you reviewing those recommendations for who surgery should be offered to. So following those, what are the main recommendations for immunotherapy for treating pleural mesothelioma? Dr. Hedy Kindler: So for a disease in which for 16 years there was only one FDA-approved regimen, pemetrexed and platinum, the pace of recent changes in systemic therapy has been a welcome change with the FDA approval of doublet immunotherapy in October of 2020 and the approval of chemo immunotherapy just a few months ago in September of 2024. Now that we have choices, we've tried to help clinicians determine the optimal treatment regimen for the individual patient. Doublet immunotherapy with ipilimumab and nivolumab should be offered as a first-line systemic option to any mesothelioma patient. For patients with non-epithelioid histology, doublet immunotherapy is hands down the recommended regimen based on the dramatic improvement in survival from 8.8 to 18.1 months for immunotherapy compared with chemo. For patients with previously untreated epithelioid mesothelioma, either ipilimumab-nivolumab immunotherapy or platinum-pemetrexed chemotherapy are reasonable options. Therapy can be individualized based on the patient's comorbidities, acceptance of differing toxicities. and treatment goals. Chemoimmunotherapy with pembrolizumab, pemetrexed, and carboplatin is a newer treatment option for patients with newly diagnosed pleural mesothelioma. This regimen is noteworthy for its very high objective response rate of 62%. Brittany Harvey: It's great to have those new options to improve outcomes for patients. Beyond the chemoimmunotherapy recommendation that you just described, what are the highlights for chemotherapy recommendations? Dr. Hedy Kindler: So pemetrexed platinum-based chemotherapy with or without bevacizumab still plays a role in this disease and should be offered as a first-line treatment option in patients with epithelioid histology. This regimen is not recommended in patients with non-epithelioid disease unless they have medical contraindications to immunotherapy. Pemetrexed maintenance chemotherapy following pemetrexed-platinum chemotherapy is not recommended. Brittany Harvey: Thank you for reviewing those recommendations as well. So then next, what are the important changes regarding pathology? Dr. Hedy Kindler: Well, one fun fact is that we've changed the name of the disease. It's no longer malignant mesothelioma. Now it's just mesothelioma. Since the non-malignant mesothelial entities have been renamed, all mesos are now considered malignant, so there's no need to use the prefix malignant in the disease name. Mesothelioma should be reported as epithelioid, sarcomatoid, or biphasic because these subtypes have a clear prognostic and predictive value. Knowing the subtype helps us decide on whether chemotherapy or immunotherapy is the optimal treatment for a patient, so it must be reported. Additionally, within the epithelioid subtype, histologic features, including nuclear grade, some cytologic features, and architectural patterns should be reported by pathology because they have prognostic significance. Pathologists have recently identified a premalignant entity, mesothelioma in situ, which can be found in patients with long standing pleural effusions and should be considered in the differential diagnosis. In the appropriate clinical setting, additional testing, including BAP1 and MTAP IHC should be performed. Brittany Harvey: Definitely. These pathologic recommendations are important for treatment selection. So in that same vein, in the final section of the recommendations, what are the updated recommendations from the panel regarding germline testing? Dr. Hedy Kindler: This is one of our most important recommendations, that universal germline testing should be offered to all mesothelioma patients. The proportion of patients with mesothelioma who have pathogenic or likely pathogenic germline variants is similar to other diseases in which universal germline genetic testing and counseling are now the standard of care. This is most commonly observed in the tumor suppressor gene BAP1 and this not only affects cancer risk in patients and their family members, but also has key prognostic significance. For example, pleural mesothelioma patients with BAP1 germline mutations who receive platinum-based chemotherapy live significantly longer, 7.9 years compared to 2.4 years for those without these mutations. Thus, we recommend that all patients with mesothelioma should be offered universal germline genetic counseling and/or germline testing. Brittany Harvey: So there were a large amount of new and updated recommendations in this update. So in your view Dr. Kindler, what is the both importance of this update and how will it impact both clinicians and patients with pleural mesothelioma? Dr. Hedy Kindler: Even as we were researching and writing this update, new data kept emerging which we needed to include. So it's clearly a time of great progress in the management of this disease. We've comprehensively reviewed and analyzed the extensive emerging data and provided clinicians with a roadmap for how to incorporate these new advances into their management of this disease. Brittany Harvey: Absolutely, that is key for optimal patient care. So you've just mentioned emerging data and rapid evidence generation, so what future research developments are being monitored for changes in the treatment of pleural mesothelioma? Dr. Hedy Kindler: Despite these recent advances in disease management, mesothelioma continues to be a lethal cancer, and there's clearly a need to develop better treatments. This includes ongoing studies of novel immunotherapeutic agents such as bispecific antibodies, cell therapy using chimeric antigen receptors targeting mesothelioma tumor antigens, and precision medicine approaches to target tumor suppressor genes. Finally, strategies for early cancer detection and prevention are vital for individuals predisposed to develop mesothelioma due to BAP1 and other germline mutations, as well as for those who are occupationally or environmentally exposed to asbestos. Brittany Harvey: Absolutely. We'll look forward to these new updates to continue development in the field. So thank you so much for this mountain of work to update this guideline, and thank you for your time today, Dr. Kindler. Dr. Hedy Kindler: Thank you so much. It's been a pleasure. Thank you for asking me to do this. Brittany Harvey: And thank you to all of our listeners for tuning in to the ASCO Guidelines podcast. To read the full guideline update, go to www.asco.org/thoracic-cancer-guidelines. You can also find many of our guidelines and interactive resources in the free ASCO Guidelines app available in the Apple App Store or the Google Play Store. If you have enjoyed what you've heard today, please rate and review the podcast and be sure to subscribe so you never miss an episode.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.      

OU Women's Gym sweeps its opening weekend and Men's Gym is counting down to the start of the season. Get caught up with the Voice of the Sooners Toby Rowland as he chats with Coach KJ Kindler and Mark WilliamsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Why did Zac Alley leave OU? KJ Kindler joins the show.

Today we're excited to be sitting down with KJ Kindler, the head coach of the 6-time NCAA Champion Oklahoma Sooners. Despite last season not ending how the Sooners wanted it to, the 2024 season was one for the history books. Oklahoma was the #1 team all season long and won its 14th and final Big 12 Championship with not only a program record score, but an NCAA team record of 198.950. KJ joins us to talk about how the team handled the heartbreak of not advancing to the NCAA finals last year, the team not being afraid to set big goals that might seem impossible, she also introduces her stellar freshmen class and gives a few updates on athlete injuries and who to watch this season. Thank you to our monthly Patreon supporters:  Lee B, Cookiemaster, Christa, Happy Girl, Erica S, Semflam, Amy C, Maria L, Becca S, Cathleen R, Faith, Kerry M, M, Derek H, Emily B, Martin, Sharon B, Randee B, MSU, Kimberly G, Robert H, Lela M, Mara L, Jenna A, Alex M, Mama T, Kelsey, Lidia, Erin S, Maria P, Alicia O, Marissa G, Cristina K, Bethany J, Diane J, Kentiemac, Marni S, Laura R, Betny T, Emily C, Cathy D, Lisa T, Libby C, Thiago, Taryn M, Dana B, Jamie S, Chuck C, Je_GL, Kaitlin, Susan P, Katertot, Maggie, Mallory D, LFC_Hokie, Ella, Debbie, Amelia G, Megan F, Kay, Diane J, Julie B,, Austin K, Jane, Sarah, Amy, Stephen S, Johanna T, Alison S, Kristina T, Abigail W, Tamar K, Becky, Ola S, Jennifer K, Kate M, Naomi S, Claudia, Siona, Resi G, Erin L, Melissa, Sarah A, Kennedy B, Thomas B, Lauren D, Kihika N, Beth C, Amy, Renee PM, Ryan V, Brandon H & Tyler!

KJ Kindler, Jeff Weber join.

Oklahoma head women's gymnastics coach KJ Kindler and 1Oklahoma's Jeff Weber joined to discuss the Sooners' signing class.

Oklahoma suffers a Missouri heartbreaker. KJ Kindler joins the program.

Which side of the divide are you on? KJ Kindler joins the show.

Grieß, Thielko www.deutschlandfunk.de, Interviews

Andy's got Mets playoff fever, confessing to comedy crimes, Andy goes full Kindler on SNL and gets hot about Coldplay, Josh tames the tiny beast in his bed, kinks in the Slinky, listener questions, and much more Spiraling. 

What a weekend of college football. Plus, OU women's gymnastics head coach KJ Kindler joins the show.

When you work in academia, you come across some very smart people. This should be surprising given that academics spend an enormous amount of time exploring whatever topic they study. And people become academic experts by digging into the particulars of areas that can be pretty narrow and focused. This is the nature of academia: develop niche knowledge in a certain area where you develop that insight throughout a career. And if you ever tried listening to some of those people talk about their work, or read their work in academic publications, you'll know that it can be very difficult to decipher precisely what they are talking about. Given the amount of time and dedication it takes to achieve academic brilliance, this shouldn't be surprising. Speaking as an academic (and not a brilliant person), this is how we are trained to communicate, and primarily to each other.One of the great things about the Ted Talk and TedX movement is that it has created a format through which people who have something to say can find the means to say it. This also has created a platform through which public scholarship can take place, and insights can be translated to a wider audience. In this era of wicked problems, disinformation, and social media, it is vital that we translate as much knowledge as possible. Nick Kindler's business is about how to help smart people improve their ability to communicate. Using an approach they call Communication Canvas, Nick with Kindler and Company give speakers the signposts they need to know the route they have to go in order to avoid verbal cul de sacs and and deliver a performance that audiences can remember. Nick draws on his experience in improv and acting, Nick talks about how it is vital that speakers bring themselves into their presentation. He discusses the importance of taking personal stories that they haven't shared, tell the story in a way that is Ted worthy, and unpack the learnings and takeaways. When we tell our stories in the right environment, it is cathartic and helps someone else. Nick asks us to focus on three key questions: How can I simplify the messaging today How can I transform using story telling and language to deep the understanding How can I deliver it and perform it in a way that engages and connects Nick Kindler LinkedIn - https://www.linkedin.com/in/nickkindlerNick Kindler Instagram - https://www.instagram.com/nick_kindler/Kindler and Company - https://www.kindlerandcompany.com/

Renee Kindler is a Family Nurse Practitioner helping busy women to boost their energy, sleep better, and think more clearly by balancing their nutrients and hormones so they can show up in their life everyday exactly how they want! She is the founder of Aonani Functional Medicine. She earned her MSN from Gonzaga University and is passionate about sharing the tremendous impact of identifying what is disrupting your sleep, making you tired, and stealing your focus. Key Topics: - What cortisol is and why you need it - When cortisol starts working against you - Symptoms of low cortisol and how to test - The cortisol-blood sugar connection - The difference between cortisol and cortisone - Why sleep is so important for managing cortisol - Reasons you're waking up in the middle of the night - The best way to prep for good sleep - How melatonin plays a role in cortisol balance Get Renee's free tips for better sleep handout at https://www.reneekindler.com/sleep Thanks to our sponsors: Factor: Head to Factormeals.com/spark50 and use code spark50 to get 50% off your first box plus 20% off your next month. Seed: Go to seed.com/spark and use code 25spark to get 25% off your first month of Seed's DS-01 Synbiotic.

Renee Kindler is a Family Nurse Practitioner helping busy women to boost their energy, sleep better, and think more clearly by balancing their nutrients and hormones so they can show up in their life everyday exactly how they want! She is the founder of Aonani Functional Medicine. She earned her MSN from Gonzaga University and is passionate about sharing the tremendous impact of identifying what is disrupting your sleep, making you tired, and stealing your focus. Key Topics: - What cortisol is and why you need it - When cortisol starts working against you - Symptoms of low cortisol and how to test - The cortisol-blood sugar connection - The difference between cortisol and cortisone - Why sleep is so important for managing cortisol - Reasons you're waking up in the middle of the night - The best way to prep for good sleep - How melatonin plays a role in cortisol balance Get Renee's free tips for better sleep handout at https://www.reneekindler.com/sleep Thanks to our sponsors: Factor: Head to Factormeals.com/spark50 and use code spark50 to get 50% off your first box plus 20% off your next month. Seed: Go to seed.com/spark and use code 25spark to get 25% off your first month of Seed's DS-01 Synbiotic.

What's it like to lead at the top of some of the world's most iconic brands? Jeff Kindler, former CEO of Pfizer, has been there, done that. From handling high-pressure situations at GE under the legendary Jack Welch to leading massive change at Pfizer, Jeff has seen all the intense scrutiny and stress and was in the room when decisions were made that shaped entire industries. In this episode, he shares what he learned from handling public pressure, how he managed the clash of corporate cultures, and why being a CEO isn't for the faint of heart. He shares major challenges he faced during his tenure at Pfizer, such as expiring patents, product recalls, R&D setbacks, and regulatory scrutiny. Jeff reflects on his leadership journey at Pfizer on the pressures of being a CEO, including mistakes made, stress management, and the impact on personal life and relationships. He also discusses the need for resilience and balancing professional and personal life. We look into why leaders might be getting a little “too soft” in today's corporate world, what it's really like when everyone is gunning for your job, and how to keep your head up when the stakes are sky-high.   ________________ Start your day with the world's top leaders by joining thousands of others at Great Leadership on Substack. Just enter your email: ⁠⁠https://greatleadership.substack.com/

Psalm 71:13-18

We're talking about sleep today on Peeling the Onion with Renee Kindler. We get into sleep habits, how to sleep better, why sleep is oh so important and also how cortisol and hormones affect our sleep. Resources:IG: https://www.instagram.com/reneekindler1/ Website: https://www.reneekindler.com/https://sachinpatel.kartra.com/page/bUW390Essential Oils Made Simple D Dimer AppThe Menopause Brain by www.hoogahealth.comwhy Why We Sleep by Matthew WalkerOxygen Advantage by Patrick McKeown Produced by NOVA Media

Nach Ansicht des Grünen-Haushaltsexperten Kindler ist die geplante Kindergrundsicherung der Koalition noch nicht gescheitert. Die Kindergrundsicherung sei ein Instrument, um vor allem Kinder aus ärmeren Familien zu unterstützen, erklärte Kindler. May, Philipp www.deutschlandfunk.de, Interviews

Kyle has been in the trucking industry for 17 years. he is the owner operator of Kin-Co Enterprises here in the DFW area. In this episode listen along to hear about Kyle's journey in the trucking industry and owning his own successful business. #dangitbenny! --- Support this podcast: https://podcasters.spotify.com/pod/show/fifth-wheel-mafia/support

KJ Kindler joins. Oklahoma Softball takes on Tulsa.

Today Mari sits down with sleep expert, Renee Kindler, to dive into all things zzzzz's.    We chat about the importance of getting good sleep, the side-effects of poor sleep and tips to help us all get a better night's rest. The crazy thing is, sleep affects everything. EVERYTHING. From our mood to our health to our longevity, sleep is where it's at.  Renee gives us some simple tools that we can utilize right away to improve our sleep hygiene and so much more. 

KJ Kindler joins. UConn repeats.

K.J. Kindler, Mark Williams join the show.

Get ready for the Baylor Series with Coach Gasso and the Big 12 Championships with KJ KindlerSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

.

KJ Kindler joins. What is this OU press conference with Porter Moser?

.

KJ Kindler joins. Arch Manning wants to "focus" on football.

.

OU Baseball has it's home opener and Skip Johnson is here to preview Wright State and recap the first four games.KJ Kindler and the OU Women's Gymnastics team is #1 in the country and back home for the next two weeks. Preview all the action with the Sooner Head Coach. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Skip Johnson previews OU Baseball and KJ Kindler previews a massive weekend in Women's GymnasticsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Elena is a certified Havening Techique™️ practitioner and trainer. Havening ~ as in safe haven ~ is a simple yet powerful technique developed by neuroscientist, Dr. Ron Ruden. The techniques can help us to experience deeper calm, inner peace and relaxation. This can also be used to help with test anxiety, PTSD, trauma healing and many other uncomfortable feelings. Check out Elena's website https://www.metamorphosishavening.com

When thinking of big time mergers of the past three decades, Wall Street memories may conjure thousands of different deals. Among the highest-profile deals, there's a good chance Robert Kindler played a role in it. From his former M&A perch at JPMorgan Chase (NYSE:JPM) to his new home at Paul, Weiss, Rifkind, Wharton & Garrison, Kindler shares stories from his upbringing, the M&A market vagaries of 2023, and his outlook for 2024. He also offers insights on inflation and the regulatory hurdles facing today's dealmakers. Inside the ICE House: https://www.theice.com/insights/conversations/inside-the-ice-house